ArticleJournal of education and health promotion2026
Comparing the pain relief effectiveness of intravenous magnesium sulfate and ketorolac versus intravenous morphine and ketorolac for kidney stones.
Article in Journal of education and health promotion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPain is one of the most common symptoms in various diseases. While morphine is widely used for pain relief, its adverse effects and potential for misuse have led to the exploration of safer alternatives. This study aimed to compare the analgesic effectiveness of intravenous magnesium sulfate versus morphine, both in combination with ketorolac, in patients with renal colic. MATERIALS AND
methodsIn this double-blind randomized controlled trial, 174 patients with renal colic referred to the emergency department of Shahid Ganjiyan Hospital in Dezful were enrolled. Patients were randomly allocated into two equal groups (
resultAmong the 174 participants included in the study, 65% were male and aged between 40 and 60 years. Statistical tests indicated no significant differences between the two groups concerning demographic characteristics. Thus, the groups are comparable in terms of demographic variables. Comparison of pain reduction between the two groups at different time points revealed no statistically significant difference. The mean pain scores decreased over time in both groups; however, the differences between the groups were not significant at 20 minutes (
conclusionThe findings of this study demonstrate that intravenous magnesium sulfate, in combination with ketorolac, is as effective as morphine-based regimens in managing acute renal colic pain. Given the current global health policies emphasizing opioid stewardship and the reduction of opioid-related adverse effects, magnesium sulfate emerges as a valuable, low-risk alternative. Its incorporation into emergency pain management protocols may not only reduce opioid dependency and misuse but also align with broader public health goals aimed at promoting safer and more sustainable pain relief strategies. Health policymakers should consider including non-opioid analgesics like magnesium sulfate in national and institutional guidelines for acute pain management, especially in settings where opioid overuse presents a clinical and social challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.